HUT60436A - Process for producing pharmaceutical composition active mainly on thrombo-embolitic conditions of circulatory system and heart - Google Patents

Process for producing pharmaceutical composition active mainly on thrombo-embolitic conditions of circulatory system and heart

Info

Publication number
HUT60436A
HUT60436A HU881484A HU148488A HUT60436A HU T60436 A HUT60436 A HU T60436A HU 881484 A HU881484 A HU 881484A HU 148488 A HU148488 A HU 148488A HU T60436 A HUT60436 A HU T60436A
Authority
HU
Hungary
Prior art keywords
embolitic
thrombo
heart
conditions
pharmaceutical composition
Prior art date
Application number
HU881484A
Other languages
Hungarian (hu)
Other versions
HU210122B (en
Inventor
Feltalalok Nevuek Feltuentet A
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Priority to HU881484A priority Critical patent/HU210122B/en
Priority to CH1014/89A priority patent/CH677732A5/de
Priority to ES8901022A priority patent/ES2014060A6/en
Priority to BE8900321A priority patent/BE1003021A3/en
Priority to GB8906856A priority patent/GB2216421A/en
Priority to LU87488A priority patent/LU87488A1/en
Priority to NL8900742A priority patent/NL8900742A/en
Priority to CA000594762A priority patent/CA1319607C/en
Priority to DE3909707A priority patent/DE3909707A1/en
Priority to FR8903812A priority patent/FR2628972B1/en
Priority to FI891438A priority patent/FI891438A/en
Priority to IT8919876A priority patent/IT1229205B/en
Priority to KR1019890003678A priority patent/KR890014104A/en
Priority to JP1069437A priority patent/JPH0222228A/en
Priority to SE8901041A priority patent/SE8901041L/en
Publication of HUT60436A publication Critical patent/HUT60436A/en
Publication of HU210122B publication Critical patent/HU210122B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HU881484A 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart HU210122B (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart
CH1014/89A CH677732A5 (en) 1988-03-23 1989-03-20
ES8901022A ES2014060A6 (en) 1988-03-23 1989-03-21 Pharmaceutical compositions acting on the heart and cardiovascular system
BE8900321A BE1003021A3 (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME.
GB8906856A GB2216421A (en) 1988-03-23 1989-03-23 Pharmaceutical compositions acting on the heart and cardiovascular system
LU87488A LU87488A1 (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING IN PARTICULAR ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THEM
NL8900742A NL8900742A (en) 1988-03-23 1989-03-23 PHARMACEUTICAL PREPARATIONS WITH AN EFFECT PARTICULARLY ON THE HEART AND THE CARDIOVASCULAR SYSTEM AND METHOD FOR THE PREPARATION THEREOF.
CA000594762A CA1319607C (en) 1988-03-23 1989-03-23 Antithrombotic pharmaceutical preparation and process for preparing same
DE3909707A DE3909707A1 (en) 1988-03-23 1989-03-23 MEDICINAL PRODUCT, SUITABLE FOR HEART AND CIRCULATION
FR8903812A FR2628972B1 (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND METHOD FOR PREPARING THEM
FI891438A FI891438A (en) 1988-03-23 1989-03-23 FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTISKA SAMMANSAETTNINGAR SOM INVERKAR I SYNNERHET PAO DET KARDIOVASKULAERA SYSTEMET.
IT8919876A IT1229205B (en) 1988-03-23 1989-03-23 PHARMACEUTICAL COMPOSITIONS ACTING IN PARTICULAR ON THE HEART AND ON THE HEART AND ON THE CARDIOVASCULAR SYSTEM AND PROCEDURE FOR THEIR PREPARATION.
KR1019890003678A KR890014104A (en) 1988-03-23 1989-03-23 Pharmaceutical composition especially acting on the heart and cardiovascular system and its manufacturing process
JP1069437A JPH0222228A (en) 1988-03-23 1989-03-23 Preparation composition acting on heart blood circulatory system
SE8901041A SE8901041L (en) 1988-03-23 1989-03-23 ANTITROMOBOTIC PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (2)

Publication Number Publication Date
HUT60436A true HUT60436A (en) 1992-09-28
HU210122B HU210122B (en) 1995-02-28

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Country Status (15)

Country Link
JP (1) JPH0222228A (en)
KR (1) KR890014104A (en)
BE (1) BE1003021A3 (en)
CA (1) CA1319607C (en)
CH (1) CH677732A5 (en)
DE (1) DE3909707A1 (en)
ES (1) ES2014060A6 (en)
FI (1) FI891438A (en)
FR (1) FR2628972B1 (en)
GB (1) GB2216421A (en)
HU (1) HU210122B (en)
IT (1) IT1229205B (en)
LU (1) LU87488A1 (en)
NL (1) NL8900742A (en)
SE (1) SE8901041L (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (en) * 1990-11-06 2000-12-04 ソニー株式会社 Electronics
KR19990015198A (en) * 1997-08-02 1999-03-05 손남율 Vegetable antibiotics
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (en) 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (en) * 2000-11-08 2005-04-01 Brif NEW DIETETIC AND / OR COSMETIC COMPOSITIONS FOR IMPROVING MUCOUS DROUGHT
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
EP1501493B1 (en) * 2002-05-03 2009-10-07 Pronova BioPharma Norge AS Use of epa and dha in secondary prevention of strokes
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (en) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition for regulation and cellular regeneration in the digestive tract, useful e.g. for treating gastroenteritis or improving animal performance, comprises essential oils, shark liver oil, selenium and water
CN101035594B (en) * 2004-08-09 2013-10-23 酶学技术有限公司 Food products for diabetics
AU2005270831B2 (en) 2004-08-10 2011-08-25 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (en) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Antiviral and immunostimulant pharmaceutical composition containing polyunsaturated fatty acid esters
WO2006113978A2 (en) 2005-04-27 2006-11-02 Jallal Messadek Insulins combinations
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
ITMI20052483A1 (en) * 2005-12-23 2007-06-24 Novamont Spa BIODEGRADABLE LURES
FR2935394B1 (en) 2008-08-29 2013-03-08 Eco Solution ORGANIC SELENIUM-ENRICHED PHOTOSYNTHETIC MICROORGANISMS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR USE IN NUTRITION, COSMETICS AND PHARMACY
FR2935393B1 (en) 2008-08-29 2012-08-24 Tetrahedron ORGANIC SELENIUM ENRICHED BACTERIA AND YEASTS FROM SELENO-HYDROXYACID COMPOUNDS AND THEIR NUTRITION, COSMETIC AND PHARMACY APPLICATIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
GB8906856D0 (en) 1989-05-10
GB2216421A (en) 1989-10-11
SE8901041L (en) 1989-09-24
NL8900742A (en) 1989-10-16
FI891438A0 (en) 1989-03-23
JPH0222228A (en) 1990-01-25
CH677732A5 (en) 1991-06-28
CA1319607C (en) 1993-06-29
HU210122B (en) 1995-02-28
FR2628972B1 (en) 1994-09-23
DE3909707A1 (en) 1989-10-05
ES2014060A6 (en) 1990-06-16
SE8901041D0 (en) 1989-03-23
IT8919876A0 (en) 1989-03-23
FR2628972A1 (en) 1989-09-29
IT1229205B (en) 1991-07-25
BE1003021A3 (en) 1991-10-29
KR890014104A (en) 1989-10-21
FI891438A (en) 1989-09-24
LU87488A1 (en) 1990-10-02

Similar Documents

Publication Publication Date Title
HUT60436A (en) Process for producing pharmaceutical composition active mainly on thrombo-embolitic conditions of circulatory system and heart
IL82192A (en) System for administration of drugs to the skin and process for the preparation thereof
GR890100314A (en) Process for the preparation of drug absorbates
IL91412A0 (en) Process and solution for the lyophilization of blood cells
HUT44779A (en) Process for producing imidazole derivatives and pharmaceutical preparations comprising the same
HUT44489A (en) Process for production of derivatives of benzosulphonamid-indanyl and medical preparatives containing them as active substance
HUT48269A (en) Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
EP0325404A3 (en) Method of immobilizing physiologically active substances
HUT47937A (en) Process for producing indoloquinoxaline derivatives and pharmaceuticals comprising these compounds as active ingredient
HUT40106A (en) Process for production of medically active derivatives of dihydropiridin and medical preparatives containing thereof
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
PT85491A (en) Process for the preparation of new (benzofuran-2-yl) imidazoles having pharmaceutical activity and their salts
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
HUT45268A (en) Process for production of tripeptide-agregations and medical preparatives containing them as active substance
HUT46039A (en) Process for producing sialosyl cholesterin and pharmaceutics comprising same as active ingredient
HUT49807A (en) Process for production of medical compositions and the active substance
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
HUT44770A (en) Process for producing 6-phenoxymethyl-4-hydroxy-tetrahydropyran-2-one derivatives and pharmaceutical preparations comprising them as active substance
HUT45083A (en) Process for obtaining neuronotrophic factor and for producing pharmaceutical comprising such active ingredient
HUT44786A (en) Process for production of quinazolin-dions, piridopirimidin-dions and medical preparatives containing them as active substance
HU896135D0 (en) Process for the preparation of 2-azabicyclo [2.2.1] hept-5-en-2-acetic acid and derivatives thereof
PL265249A1 (en) A method of a pharmaceutical agent and its active matter production
CS534487A2 (en) Fungicide and method of this agent's active substance production

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: BIOREX KUTATO ES FEJLESZTOE RT., HU

HPC4 Succession in title of patentee

Owner name: HERBARIA GYOGYNOVENYFELDOLGOZO ES KERESKEDELMI RES

HC9A Change of name, address

Owner name: HERBARIA GYOGYNOEVENYFELDOLGOZO ES KERESKEDELM, HU

Free format text: FORMER OWNER(S): BIOREX KUTATO ES FEJLESZTOE RT., HU; BIOREX KUTATO-FEJLESZTOE KFT., HU; HERBARIA GYOGYNOEVENYFELDOLGOZO ES KERESKEDELMI RESZVENYTARSASAG, HU